-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DK8in3yWmOAVeApvKdmFXKKVpR0g92SSh9dQb9fh2orsV13yiqVu2NSvFMQ1Di6Y d4kUfBpSYAQtoMmwo5y5mQ== 0000950134-02-010762.txt : 20020829 0000950134-02-010762.hdr.sgml : 20020829 20020829092939 ACCESSION NUMBER: 0000950134-02-010762 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020829 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: FEMALE HEALTH CO CENTRAL INDEX KEY: 0000863894 STANDARD INDUSTRIAL CLASSIFICATION: FABRICATED RUBBER PRODUCTS, NEC [3060] IRS NUMBER: 391144397 STATE OF INCORPORATION: WI FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-41498 FILM NUMBER: 02751810 BUSINESS ADDRESS: STREET 1: 919 N MICHIGAN AVE STREET 2: STE 2208 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 3122802201 MAIL ADDRESS: STREET 1: 919 N MICHIGAN AVE STREET 2: SUITE 2208 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: WISCONSIN PHARMACAL COMPANY INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BENSON GARY CENTRAL INDEX KEY: 0001180094 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: C/O REGENCY ATHLETIC CLUB STREET 2: 1300 NICOLLET MALL STE 600 CITY: MINNEAPOLIS STATE: MN ZIP: 55403 BUSINESS PHONE: 2484363896 MAIL ADDRESS: STREET 1: C/O REGENCY ATHLETIC CLUB STREET 2: 1300 NICOLLET MALL STE 600 CITY: MINNEAPOLIS STATE: MN ZIP: 55403 SC 13D 1 c71402sc13d.txt SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* THE FEMALE HEALTH COMPANY - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, $.01 per value - -------------------------------------------------------------------------------- (Title of Class of Securities) 314462 10 2 - -------------------------------------------------------------------------------- (CUSIP Number) Gary Benson Regency Athletic Club 1300 Nicollet Mall, Suite 600 Minneapolis, MN 55403 Phone: (952) 474-9432 With a copy to: William M. Mower, Esq. Maslon Edelman Borman & Brand, LLP 3300 Wells Fargo Center 90 South Seventh Street Minneapolis, MN 55402-4140 Phone: (612) 672-8200 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) MAY 18, 1999 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box / /. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Section 240.13d-7 for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13D CUSIP NO. 314462 10 2 Page 2 of 5 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS/I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Gary Benson - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS (See Instructions) PF - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States of America - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER NUMBER OF 1,421,000 SHARES ----------------------------------------------------------------- 8 SHARED VOTING POWER BENEFICIALLY OWNED BY EACH ----------------------------------------------------------------- 9 SOLE DISPOSITIVE POWER REPORTING 1,421,000 PERSON ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER WITH - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,421,000 - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [x] - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 8.3% - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON (See Instructions) - -------------------------------------------------------------------------------- 2 ITEM 1. SECURITY AND ISSUER This statement relates to the common stock, $.01 par value, of The Female Health Company., a Wisconsin corporation ("Female Health Co"). The address of Female Health Co.'s principal executive offices is 515 N. State Street, Suite 2225, Chicago, IL 60610. ITEM 2. IDENTITY AND BACKGROUND This Schedule 13D is being filed by Gary Benson. Mr. Benson's business address is Regency Athletic Club, 1300 Nicollet Mall, Suite 600, Minneapolis, MN 55403. Mr. Benson is a private investor. During the last five years, Mr. Benson has not been (i) convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors), or (ii) party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Mr. Benson is a citizen of the United States of America. ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION Not applicable. ITEM 4. PURPOSE OF TRANSACTION The shares of Female Health Co subject to this Statement are held by the Reporting Person solely for investment purposes. Although the Reporting Person has not formulated any other definitive plan, he may from time to time acquire, or dispose of, common stock and/or other securities of the Company if and when he deems it appropriate. The Reporting Person may formulate other purposes, plans or proposals relating to any of such securities of the Company to the extent deemed advisable in light of market conditions, investment policies and other factors. Except as indicated in this Statement, the Reporting Person has no current plans or proposals which would relate to or would result in any of the matters described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. 3 ITEM 5. INTEREST IN THE SECURITIES OF THE ISSUER a.- b. Mr. Benson beneficially owns 1,421,000 shares (includes 300,000 shares of common stock and 21,000 shares of preferred stock owned by Goben Enterprises, LP, a limited partnership of which the reporting person is a general partner. Also includes warrants to purchase 1,100,000 shares owned by Goben Enterprises, LP). According to the Company's Form 10-QSB the number of shares outstanding as of May 14, 2002 was 16,008,588. Accordingly, based upon this information Mr. Benson owns 8.3% of the outstanding shares. c. TRANSACTIONS WITHIN THE LAST 60 DAYS --------------- --------------- ------------ Date Acquired No. of Shares Price* --------------- --------------- ------------ 7/22/02 300,000 $1.61 --------------- --------------- ------------
* The above acquisition was a private transaction with the Issuer. The price is based upon the last sale price of the shares on the date acquired. d. Not applicable. e. Not applicable. ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS WITH RESPECT TO SECURITIES OF THE ISSUER None. 4 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: August 28, 2002 /s/ Gary Benson ------------------------- Gary Benson 5 EXHIBIT A This information is provided for informational purposes only. Entity Number of shares ------ ---------------- Charitable Remainder Trust (of which the 81,450 (1) reporting person is not a trustee)
(1) The reporting person is not a trustee of such trust and disclaims beneficial ownership of any shares held by such trust. 6 -----END PRIVACY-ENHANCED MESSAGE-----